We found that LLL12 (Figure 3C) and Stattic (Figure 3D) could inhibit cell viability of the ALDH+ subpopulation from MDA-MB-231, SUM159, and SK-BR3 cells, although LLL12 is more potent than Stattic in terms of inhibiting breast cancer initiating cell viability. The gene discussed is LDHA; the disease is breast carcinoma.